LIVE AUDIO WEBCASTS Is Patient Compliance Your Next Blockbuster Drug?
Thursday, May 28, 2008
2pm –3pm ET
Pharmaceutical manufacturers spend billions of dollars each year on the research and development that will produce their next successful product.
But in the wake of stagnant development pipelines and growing competition from generics, many manufacturers are taking a closer look at patient compliance as a way to drive product success and boost financial results. Join us for an in-depth Webcast that provides insight on how compliance rates affect clinical outcomes, market perception and product revenue?as well as what manufacturers can do about it.
click here.
Register Free at www.pharmexec.com/patientcompliance
Sponsor:
AmerisourceBergan Specialty Group
Next Generation Pharma CRM
Tuesday, June 3, 2008
11am – 12pm ET
A panel of industry experts will discuss the future of Customer Relationship Management (CRM). Using insights from data collected during a recent research project, the panelists will remark on the changes in the pharmaceutical sales organizations, challenges around CRM adoption, and Closed Loop Marketing. Q&A from the Webcast attendees will round out the one hour discussion.
click here.
Register Free at www.pharmexec.com/pharmacrms
Sponsor:
Cegedim Dendrite Value-Based Reimbursement: New Strategies for a Changing Marketplace
Wednesday, June 4, 2008 2pm – 3pm ET
In today's increasingly cost-conscious environment, traditional tactics are no longer enough. To successfully market a drug, it?s vital to manage the often conflicting objectives and motivations of a whole range of healthcare system stakeholders. The best marketing strategies see reimbursement as a series of value-benefit transactions that span the entire chain from manufacturer to patient.
click here.
Register Free at www.pharmexec.com/reimbursement
Sponsor:
Boston Healthcare
Emerging, Provider-facing Technologies: How They Impact Prescribing Decisions and Patient Care
Thursday, June 26, 2008 2pm – 3pm ET
More than any other specialty, oncology faces tremendous scrutiny and pressure to reduce the cost of care. Public and private payers, as well as oncology practices themselves, seek new methods for decision support and quality measurement. New technology solutions are coming to market to meet these needs?but what impact will they have on product use and patient care? Join us for an in-depth Webcast that provides insight on how these new technologies may have a profound effect on the future of oncology relative to clinical decisions, benchmarking, quality control, outcomes analysis and practice efficiencies.
click here.
Register Free at www.pharmexec.com/oncologytechnology
Sponsor:
ION ON-DEMANDS NOW AVAILABLE FOR REPLAY Use of Named Patient Programs to Enhance Global Market Access
Original Broadcast: May 7, 2008The success of new product launches has become more critical than ever. Pharmaceutical and biotech companies require market access strategies that are increasingly innovative and global in nature to enable appropriate patient access.Named Patient Programs can provide significant value to the sponsoring company through physician and pharmacist engagement and education, real-life data capture, and product visibility as part of a market access strategy.
click here » Replay Free at www.PharmExec.com/marketaccess
Sponsor:
IDIS
Preparing for externalization: How does your company exchange confidential documents?
Original Broadcast: April 17, 2008Are you ready for externalization? Sharing proprietary and critical information between Biopharmaceutical companies is not just a technical challenge; it’s the core challenge facing the industry — How will companies work effectively and securely with a variety of partners to bring new products to market, utilize outside resources, and develop new business relationships?
This challenge impacts every facet of Biopharma - from R&D executives sharing trial designs and results with CROs; business development officers performing due diligence; manufacturing executives communicating specifications to a contract manufacturer; to marketers working with key opinion leaders. To learn more about this topic, click here » Replay Free at www.PharmExec.com/Externalization
Sponsor:
IntraLinks
Cardiac Safety in Large Molecules:
New Regulatory Expectations, New Strategies
Original Broadcast: February 26, 2008Those who oversee development of large molecule drugs need to be up-to-date on cardiac safety issues, the science, the current state of regulation, and the emerging trends. To help fill the knowledge gap, we are pleased to offer this free webcast, featuring representatives from industry, academia, and the FDA. This includes members of the collaborative Cardiac Safety Research Consortium, a group that has taken the lead in understanding and interpreting current standards of cardiac safety. To learn more about this topic and the panelists, click here. » Replay Free at www.PharmExec.com/CardiacSafety
Sponsor:
Quintiles
Patient-Centric Insights:
“New Essentials” that Will Transform Your Sales & Marketing Strategy
Orginal Broadcast: February 13, 2008
If you are involved with pharmaceutical commercialization, you know how important it is – especially given today’s challenging market/environment – to make use of every available tool to achieve outstanding brand performance. To find out more about why patient insights need to be an essential part of your toolkit, and to discover how to put them to work for you, we encourage you to attend this
free one-hour Web seminar. To learn more about this topic and the panelists, click here. PROVIDING GLOBAL, PRE-APPROVAL ACCESS TO INNOVATIVE MEDICINES: LEGALLY AND ETHICALLY
Original Broadcast: October 3, 2007
An expert panel will discuss the structure of Named Patient Programs, the medical and regulatory implications of these programs, the benefits to the sponsoring company, and strategies for launching and operating these programs. The Webcast features a case study describing the benefits of a Named Patient Program to the sponsoring company, physicians, and patients. To learn more about this topic and the panelists, click here.
» REPLAY this Free Webcast
Sponsor:
IDIS
CLINICAL EDUCATOR TEAMS: IS IT RIGHT FOR YOUR BRANDS?
Original Broadcast: July 24, 2007 Education—of prescribers, practice staff, and patients—is the key to compliant pharmaceutical drug usage and successful health outcomes. And today, the most innovative and useful tool for educating pharma stakeholders is the clinical educator team. Watch this free webcast, featuring a panel drawn from pharma, medicine, and patient population, to learn the basics of how to work with clinical educators and how to coordinate it with your existing marketing effort. To learn more about this topic and the panelists, click here. » REPLAY this Free Webcast Sponsor:
Innovex
MEDICARE PART D’S IMPACT ON PATIENT ASSISTANCE PROGRAMS
Original Broadcast: June 14, 2007 View a free, informative Webcast featuring the latest on this complex federal program
Pharmaceutical companies rely on patient assistance programs as an essential strategy for maintaining accessibility to vital drugs. But now, in the world of Medicare Part D, these same assistance programs can present unprecedented complexities. Join us on June 14 at 2pm EDT for an in-depth Webcast that explores Medicare Part D’s influence on patients, the concerns and requirements of federal agencies, and solutions for manufacturers.
» REPLAY IT FREE Sponsor:
AmerisourceBergen Specialty Group
VIDEO
Decode the DNA of Global Product Launches: What Defines True Launch Excellence?
Original Broadcast: May 23, 2007 With fewer than 6% of new product launches succeeding, the stakes are enormously high for marketers as launches can represent the single most value-creating event in a company’s year as well as its largest, single non-R&D investment. The main culprit for these failures — marketers that adopt a “one-size-fits-all” strategy while ignoring cultural nuances and failing to customize their launch to the specific geography. » REPLAY IT FREE Sponsor:
IMS |
